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Investigations into the development of potential bone substitutes 
have increased rapidly in the last decade. Titanium and cobalt chrome are 
currently the alloys of choice when it comes to the orthopedic medical 
device fields due to their excellent mechanical strength and corrosion-
resistant properties. Yet these materials are unable to elicit a biologically 
functional bone-material interface without a bioactive surface coating or 
surface modification. Osteoconductivity is only achieved when suitable 
coatings are applied or their surface properties are suitably altered. The 
need for significant bony reconstruction implants as a result of prosthetic 
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revision surgery also increases the need to produce longer lasting or 
permanent bone substitute materials.  
Hydroxyapatite is the principle constituent of bone and has been used 
as a mechanism to induce bone formation at particular biological sites in 
need of bone repair and growth. When applied as a surface coating, 
hydroxyapatite’s chemical and physical properties allow osteointegration 
of medical devices and prostheses. The discovery of hydroxyapatite has 
resulted, not only in rapid advances and developments in the orthopedic 
and dental fields, but has also lead to a surge in investigations into further 
tailoring of the material to create new devices that meet clinical needs. 
Currently, the most commonly used method for assessing the potential 
bioactivity and bone-bonding ability of a material in-vitro involves using 
simulated body fluid. Previous research by Kokubo et al. has shown that 
in-vitro results obtained using these experiments correlate directly to in-
vivo results and thus satisfies their use as potential bone-tissue substitutes.  
Porous silicon is a bioactive material and has been the subject of 
intense research since its original discovery at the Bell labs in 1956. 
Canham et al. was the first to suggest the possibility of creating 
biologically interfaced devices from porous silicon given its biostability, 
non-toxicity and ease of its topographical manipulation and 
optoelectronic properties. Porous silicon has been shown to induce the 
formation of a physiologically stable hydroxyapatite on its surface using 
in-vitro simulated body fluid experiments. Other studies today are also 
exploring the use of porous silicon as a promising potential bioactive 
therapeutic agent and drug delivery vehicle. Further research exploring 
the potential of using a silicon-substituted hydroxyapatite coating in in-
vitro experiments have showed improved bioactivity and chemical 
stability under physiological conditions compared to normal 
hydroxyapatite. In 2010, Chadwick, Clarkin and Tanner showed that 
metallurgical grade porous silicon powder induced bone-like apatite 
formation on its surface in simulated body fluid inferring a bioactive 
nature and likely close bony apposition in-vivo. This chapter explores the 
use of porous silicon as a biomaterial and hydroxyapatite and porous 
silicon as a potential biomaterial for bone tissue engineering and other 
bioactive applications. It examines current research and future directions 





From a biological perspective Si is an essential trace element which has 
been linked to the health of connective tissues and bones [1]. Previous 
research investigating the role of Si within the body has shown that increased 
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dietary Si is associated with increased bone mineral density (BMD) in the 
cortical hip bone of a range of subjects [2]. Large differences were observed in 
BMD values (up to 10%) for a dietary intake of between the greater than 40mg 
Si/day and the less than14 mg Si/day quintiles of Si intake.  
The range of subjects included 1295 men (aged 59.4 +/- 9.6 years), 306 
premenopausal women (aged 47.0 +/ 4.7 years) and 1325 postmenopausal 
women (aged 61.4+/- 8.3 years). Dietary Si was obtained from food sources 
such as cereals/grains and their products such as breakfast cereals, bread, beer, 
and some fruits and vegetables such as bananas, beans and lentils [2]. This 
research shows that Si can be used to stimulate bone growth through an 
increased dietary or supplement intake. The average dietary intake currently 
for Si is between 20-50mg Si/day in the Western world [2]. Carlisle et al. first 
reported the presence of Si (0.5 wt%) in-vivo within the mineral osteoid 
regions such as the active calcification sites of normal tibia from young mice 
and rats [3].  
It was also demonstrated that Si supplemented embryonic chick bones 
showed a 100% increase in collagen content over Si-low bones after 12 days 
in culture [4]. Studies of skeletal development in Si-depleted chicks showed 
reduced circumference of leg bones with a thinner cortex and reduced 
flexibility [5].  
Hydroxyapatite (HA), is a biomimetic calcium phosphate (CaP) ceramic 
with a similar composition to bone mineral [6]. It is bioactive and has been 
therefore used in dental and medical applications including coatings for hip 
replacements and bone grafting materials for filling bone cavities [6]. Silicon, 
when substituted into HA has been shown to improve bioactivity and increase 
the bone bonding ability of the ceramic (see Table 1).  
Carlisle et al. has shown that Si is concentrated in the active bone growth 
sites of young mice and rats (co-localized with osteoblasts) and increased 
together with the level of Ca in osteoid tissues [5]. 
 
Table 1. Comparison of in-vitro and in-vivo bioactivity  
of HA and Si-HA [7-8] 
 
 HA 0.8 wt.% 1.6 wt.% 
Time required to form a 
surface layer of apatite in-
vitro (days) 
24 17 11 
Percentage bone/implant 
coverage at 23 days in-vivo 47.1%±3.6 59.8%±7.3 - 
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As the bones develop or ‘mature’, the Si levels diminish as Ca levels 
increase to those of fully mineralized bone. This research suggests that Si may 
have a role in the development of an organic matrix and subsequent initiation 
of calcification and is further evidenced by the concentrations of collagen and 
glycosaminoglycins which are suppressed in Si deficient animals while the 
mineral composition of bone is largely unaffected [5]. Glycosaminoglycins are 
shown to be associated with Si in numerous tissue types and it has been 
indicated that Si is associated with organic phosphorus prior to calcification 
[5].  
These results support the arguments that Si has a role in co-coordinating 
glycoprotein phosphorylation reactions with collagen prior to the growth of 
HA crystals [5]. 
 
 
POROUS MATERIALS  
 
Porous materials can be defined as any solid material containing pores [9]. 
The porosity of a material generally means the fraction of pore volume to the 
total volume of the material. It consists of individual openings, spacings or 
interconnecting pores [9].  
Porosity can occur at a substrate surface or can completely penetrate 
through a bulk material [10]. According to the IUPAC (International Union of 
Pure and Applied Chemistry), porous materials are divided into three 
categories: microporous or nanoporous (<2nm), mesoporous (2-50 nm) and 
macroporous (>50nm) [11].  
Pores within a material are classified into two types: open pores and 
closed pores [9]. The open pores connect to the outside of the material whilst 
the closed pores are isolated from the outside and may contain a fluid. Most of 
the industrial applications today require porous material with open pores.  
Porous materials for filters and carriers for catalysts and bioreactors need 
to have a high fraction of open porosity. Closed porous materials are used 
mainly for sonic and thermal insulators or low-specific-gravity structural 
components [9].  
Nano-porous materials abound in nature both in biological systems and in 
natural minerals. Bulk nano-porous materials which can be visualised as 
diminutive sponge-like substances, are gaining increasing importance in 
industrial applications such as molecular sieving, ion exchange and catalysis 
[12]. 
Hydroxyapatite Formation … 5
POROUS SILICON 
 
Porous silicon (PS) is considered a sponge-like structure created by either 
electro-chemical or chemical etching of bulk silicon [13]. This produces a 
random array of pores within the silicon material. PS was originally 
discovered by Arthur Uhlir Jr. and his wife Ingeborg, at the Bell laboratories 
in the US between 1955 and 1956 [14]. Uhlir and Ingeborg were developing a 
technique for cleaning, polishing and shaping the surfaces of germanium and 
silicon by electrochemical etching in hydrofluoric (HF) acid solutions [14]. 
Uhlir discovered that low current densities would induce a red or black crude 
product in the form of a thick film on the surface of the material. In 1971, 
Watanabe and Sakai demonstrated the first application of PS in electronics 
with ‘full isolation by the porous oxidized process’ (FIPOS), where the PS 
layers were used for device isolation in integrated circuits [15]. The main 
focus of research during this period was based on using oxidised porous 
silicon as a dielectric isolator [14]. Then, in the late 1980’s, at the Defence 
Research Agency in England, Leigh Canham discovered that PS was able to 
display quantum confinement effects. In a published experiment in 1990 it was 
revealed that silicon wafers can emit light if subjected to electrochemical and 
chemical dissolution [16]. This particular phenomenon is known as 
photoluminescence. Major interest has since grown concerning the uses and 
various applications that could arise from using PS [16].  
 
 
POROUS SILICON FORMATION 
 
The two most commonly employed methods applied to achieve PS 
formation are electro-chemical etching and chemical etching of Si in HF based 
solutions [17-18]. In the case of electrochemical etching of pure intrinsic Si 
wafers, it is generally accepted that only a hydrogen (H) passivated surface 
layer results [19]. Hole injection and doping in bulk Si wafers prior to etching 
is essential to allow the HF electrolyte penetrate into voids and attack the 
material thereby resulting in the initial dissolution phase of the Si surface layer 
and a porous surface structure being formed [19]. The anodisation cell can be 
one of three types such as a lateral cell, single-tank or double tank cell and the 
potential current applied, usually a constant current at low current density, 
allows maximum control of parameters such as porosity, thickness and 
uniformity of the final PS layer structure [20]. Pore initiation and dissolution 
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in the Si wafer material is however, still under some review with different 
mechanisms being proposed [20].  
It is now generally accepted though that bulk Si must be doped and 
contain holes before applying an electrochemical etching procedure to initiate 
pore formation [20]. HF is considered unreactive with a pure bulk Si surface 
because once it removes any oxide layers it leaves the surface hydrogen 
terminated with one H atom bound to each surface Si atom. To initiate further 
reactivity and induce etching, the H-terminated surface must be activated 
either electrochemically (applying a sufficient voltage) or chemically (adding 
an oxidant with a sufficient electrode potential). This formation of H bubbles 
on the surface gives rise to inhomogeneous microporous Si formation [19]. 
The application of the anodisation cell and potential current results in an 
electron being removed from the Si-H bond created initially, thus causing a 
hole (a vacancy in the Si valence band).  
The previously passivated Si-H bond is now activated and becomes 
susceptible to attack by the fluoride solution [21]. Etching now proceeds 
rapidly inducing pore formation. Once the pore is formed it is the constant 
potential current that maintains an invariable concentration of HF at the pore 
tips leading to a more homogenous in-depth porous layer structure being 
formed [18].  
Properties of the Si material such as pore size, volume and depth in this 
instance, are very much dependant on the anodisation conditions applied, for 
example: HF concentration, type of wafers (N-type or P-type), 
crystallographic orientation, current density, anodisation duration [18]. These 
properties are then tuned to the desired ranges by tailoring the anodisation 
conditions.  
Chemical etching or stain etching applied to Si wafers is a much easier but 
less frequently employed technique. The key mechanism to form PS is through 
the etchant solution used (HF, HNO3 and water (H2O)). It is believed Nitric 
Oxide (NO) is produced on the surface of the Si which serves as the hole 
injector [17]. HNO3 then serves as the catalyst for porous layer formation [17]. 
Various mechanisms are again proposed for the overall dissolution chemistry 
associated with PS formation through this method [17, 22-23] but in general 
the porous layer structure is formed under similar conditions to the electro-
chemical etching method discussed previously.  
Another key to forming a porous layer structure through chemical etching 
is the application of certain elements onto the Si surface such as a thin 
aluminium (Al) film onto a Si substrate [24]. Dimova-Malinovska, D. et al. 
showed that the Al film (up to 200nm in size) actually reacted with the HF 
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solution and in this case was the mechanism for hole initiation and the porous 
structure formation [24]. Up to 1µm thick porous layers on Si wafers can be 
developed using this method.  
Most electrochemical etching procedures can induce porosity up to a few 
microns thick depending of course on the relative size of the Si wafer or Si 
particle [17]. Gold (Au) assisted electro-less etching has been seen to cause 
much deeper pore formation into Si wafers [25]. A nanometre sized Au film 
(~4nm) is deposited onto doped wafers which upon reaction with the HF based 
solution causes breaking of the film into tiny Au particles on the surface of the 
Si wafer.  
The applied etching conditions causes pore formation at the position of the 
Au particles on the surface and relative to the size and morphology of the 
particles formed [25]. Metal-assisted etching using thin films of platinum (Pt) 
and silver (Ag) on Si has also been documented as the critical elemental 
factors to inducing PS formation [26-28].  
Incorporating iron (Fe) into HF solutions has also been shown to affect the 
etching process to some degree [29]. The application of electroless, electro-
chemical and chemical etching procedures applied to Si is now well 
documented [22-23].  
 
 
METALLURGICAL GRADE POROUS SILICON 
 
Metallurgical Grade Porous Silicon (MGPS) powder contains impurities 
including Fe, Al, Ca, carbon (C) and oxygen (O) [30-32]. During the 
manufacturing process it is believed that these impurities are a result of the 
smelting and grinding process applied to make the Metallurgical Grade Silicon 
(MGSi) powder [30]. 
Previous studies have shown that MGSi powder contains a host of 
impurities with Fe, Al and Ca being heavily deposited at the grain boundaries 
of the material [31]. Vesta Ceramics (Hisings Backa, Sweden) are a leading 
manufacturing company in producing PS from MGSi powder. They 
incorporate a jet-milling process on larger particulate sized MGSi powder to 
break the powder into micron size particles [30].  
During the milling process, these powder particles will fracture along 
grain boundaries where impurities are segregated and therefore particles will 
have more impurities on the surface. These impurities then react with the 
chemical etchant applied causing hole initiation and PS formation at the 
surface relative to the etching rate of Si [30].  
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METALLURGICAL GRADE POROUS SILICON STRUCTURE 
 
The particle morphology was studied from a series of SEM images, 
obtained using a Hitachi SU-70 SEM. The images in Figure 1 represent 
samples 2E-100, 2E-60 and 2E-Bulk. These three samples of MGSi powders 
are as follows (‘2E’ refers to the specific grade of material): 
 
1) 2E-Bulk – The starting MGSi powder used to make MGPS particles  
2) 2E-100 – MGPS powder manufactured from the 2E-Bulk powder 
after chemically etching for 100% of the required etching time (100% 
etching time is defined as the point when the sample exhibits 
photoluminescence with an ultraviolet light [30]) 




Figure 1. SEM images of selected Si particles in samples 2E-100, 2E-60 and 2E-Bulk. 
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The MGPS particle size ranges from 4 - 5 µm with pore sizes ranging 
from 8 - 15 nm in diameter. The random, pitting dispersion of pores on the 
surface of the MGPS particles is clearly visible. Sample 2E-100 displays a 
high surface porosity with the surface pores almost coalescing in some cases. 
The pores in sample 2E-60 are characteristically more spaced out. They also 
appear shallower in comparison to sample 2E-100. The solid surface of sample 
2E-Bulk clearly shows no pore formation prior to the chemical etching 
process.  
Previous studies have used tomography to obtain various morphological 
characteristics of materials as well as pore information [33-34]. Two MGPS 
particles were isolated from sample 2E-100 and Transmission Electron 
Microscopy (TEM) images were recorded at tilt angles about the x-axis 
ranging from -37° to +37° at 2° intervals.  
Using IMOD image analysis software [35], they were then built into a tilt 
series. From the tilt-series, the core of the MGPS particle in Figure 2a is 
observed, indicating a thicker core region compared to the outer region of the 
particle, but it is not possible to tell from the TEM tilt series if this section is 
porous or not.  
In Figure 2b, the tilt series for the smaller MGPS particle, shows that the 
pores seem to penetrate all the way through.  
 
 
Figure 2. TEM micrographs of MGPS particles (a) and (b) used for tilt series from 
sample 2E-100. 
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Figure 3. SEM images of fractured particles from sample 2E-100 prepared using a 
mortar and pestle [32]. 
The main limitation of this technique in this case is that the particle size is 
generally too large to allow electrons to penetrate through and is therefore 
limited to particles with thicknesses of less than approximately 200nm. Due to 
this limitation, it was not possible to construct a full tomographical series for 
this sample. A structural study completed by Chadwick et al showed the 
smaller sized MGPS particles < 2µm in diameter to be completely porous 
throughout [32]. Larger MGPS particles have a solid Si core and a porous 
outer shell. 
In order to observe the pore structure beneath the surface of the MGPS 
particles, sample 2E-100 was crushed with a mortar and pestle and analysed 
with SEM as shown in Figure 3. The results indicate an interconnected pore 
network existing beneath the surface of the MGPS particles. In keeping with 
other observations from this study, the pores observed are randomly oriented 
and numerous. The size of the pore channels range from 7-12nm which also 




SIMULATED BODY FLUID 
 
In 1991, Kokubo and Takadama outlined that the essential requirement for 
an artificial material to bond to living bone in-vivo requires the formation of 
bone-like apatite on its surface and that this in-vivo apatite formation could be 
reproduced using simulated body fluid (SBF) with ion concentrations nearly 
equal to those of human blood plasma [36]. Thus, the in-vivo bone bioactivity 
can be assessed in-vitro using SBF. The formation of a bone-like apatite layer 
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on the surface of a material creates the bond between the substrate material 
and living bone. Bioactive glasses, apatite containing glass-ceramics, 
composite glass-ceramics, sintered HA and apatite β-tricalcium phosphate 
biphasic ceramic were all found to produce an apatite layer on their surface in 
SBF and when implanted in-vivo they also bonded to living bone through 
formation of a CaP apatite layer [36]. Thus, the direct correlation between in-
vitro results and in-vivo results are once again clarified.  
The precipitation of bioactive calcium phosphate in SBF is governed by 
complex thermodynamics, consisting of seventeen association / disassociation 
reactions [37]. SBF is a supersaturated solution with respect to apatite; 
however, it does not spontaneously deposit apatite during storage at 36.5°C 
indicating that the degree of supersaturation is not so high as to induce 
homogeneous apatite nucleation. Tanihara et al. identified the factors, which 
govern heterogeneous apatite nucleation on a substrate [38]. The rate, I, of 
heterogeneous nucleation of a crystal on a substrate in a solution at 


















GII o expexp    (Equation 1) 
 
where: 
∆G is the free energy for the formation of an embryo of crystal size 
∆Gm is the activation energy for transport across the nucleus-solution 
interface.  
Of these ∆Gm is independent of the substrate. ∆G is given by Equation 2. 
 
∆G = 16Ơ3f(θ) / 3(kT/Vβ ln(IP/Ko))    (Equation 2) 
 
where: 
σ = the interface energy between the nucleus and the solution. 
IP = the ionic activity product of the crystal in the solution. 
K0 = the value of IP at equilibrium (the solubility of the crystal). 
( )θf  = a function of constant angle between the nucleus and the 
substrate.  
βV = the molecular volume of the crystal phase.  
Among these terms ( )θf  depends on the substrate and IP/K0, a measure 
of the degree of supersaturation also depends on the substrate when the 
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substrate releases some constituent ions of the crystal. Therefore an increase in 
the ionic activity product or a decrease in ( )θf  is effective for heterogeneous 
apatite nucleation [37]. An increase in the ionic activity product of apatite can 
be facilitated by release of Ca2+, PO3-4, or OH-, which are constituents of 
apatite. Among these, Tanihara et al. state that increasing Ca2+ is most 
effective [38]. 
Lu and Leng carried out thermodynamic and kinetic analysis of SBF and 
found that HA precipitation exhibits a higher thermodynamic driving force 
than octacalcium phosphate (OCP) or dicalcium phosphate dehydrate (DCPD) 
even though OCP precipitation is kinetically favourable in SBF. Similarly, 
DCPD does not have a thermodynamic driving force of precipitation in SBF, 
even though it has kinetic advantages in nucleation. Generally, precipitation of 
carbonate-containing HA is more kinetically favourable than that of 
stoichiometric HA and has the same level of thermodynamic driving force; 
precipitation of calcium-deficient HA is also more kinetically favourable, but 
its thermodynamic driving force is lower than that of stoichiometric HA [37]. 
On the basis of the thermodynamic principals that govern apatite 
precipitation, a mechanism of apatite formation can be explained. There are 
two important factors pertaining to apatite formation in SBF. The first is the 
release of ionic species to increase the degree of supersaturation of the 
surrounding fluid with respect to apatite, the other is the existence of 
favourable sites for heterogeneous nucleation. For bioglass, the following 
mechanism is proposed. Upon immersion in SBF, dissolution of the material’s 
surface occurs and results in the release of Ca2+ ions into solution and the 
formation of Si-OH groups. At the interface, the degree of supersaturation of 
SBF increases with respect to apatite until the free energy barrier for the 
formation of a critical nucleus ∆G is reached. Once reached, crystal nucleation 
begins at precise sites along the substrate surface and crystals attach at specific 
sites along the substrate (e.g. Si-OH groups). Once the critical nucleus is 
attached to the substrate it grows by the ionic deposition of Ca2+, PO3-4 and 
OH- from solution onto the growing nucleus, with neighbouring crystals 
imposing space restrictions thus governing the direction of the growth. The 
process continues until the surface has been fully covered and a bioactive 
surface layer of CaP has been formed. It has been speculated that apatite 
formation on silica gel is induced by silanol groups on its surface. However, it 
has also been proposed that pores play an important role in nucleating the 
apatite, rather than the silanol groups [39-40]. In studies by Pereira et al. 
induction time for apatite formation on a silica gel in SBF was shown to 
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increase with decreasing pore volume and pore size, as such it was postulated 
that negatively charged pores larger than a 2 nm radius provide favourable 
conditions for the apatite nucleation and hence act as nucleation sites [41-42]. 
On the other hand, West and Hench proposed, on the basis of molecular orbital 
calculations, that surface defects such as trisiloxane rings are effective for the 
apatite nucleation [43]. 
Cho et al. found that neither the presence of the silanol groups nor that of 
the trisiloxane rings is a sufficient condition for apatite nucleation and that the 
presence of pores larger than 1.7 nm is also an insufficient condition for the 
apatite nucleation [44]. However, it was speculated that a certain type of 
structural unit of silanol groups was effective for apatite nucleation.  
It is important to note at this point that while SBF in vitro tests are 
considered an essential ‘guide’ for predicting in-vivo bioactivity and 
determining the bone bonding ability of a material, it is also possible for some 
materials to invoke a successful in-vivo response even though they were 
unsuccessfully trialed in SBF. Bohner and Lemaitre outlined certain aspects of 
the current and established SBF which is used by many researchers, which 
could be improved upon to further resemble blood serum [45]. It is proposed 
that the simplest SBF solution should be in equilibrium with DCPD [45]. The 
current SBF used however, is also established as the main method for 
exploring potential in-vitro bioactivity. 
 
 
POROUS SILICON BIOMATERIALS AND BIOACTIVE 
SILICON COATINGS 
 
Biomaterials are a select group of materials used for medical treatment 
within the human body [46]. They can be either modified natural or synthetic 
materials which find application in a wide variety of medical and dental 
implants and prosthesis used for repairing, enhancing or replacing natural 
tissues [47]. A key element of biomaterials is that they must assist in a medical 
function or capacity while maintaining compatibility with human organs and 
tissues [46]. Examples of clinical biomaterial applications today include joint 
replacement, vascular grafts and heart valves [47]. In terms of potential bio 
applications of Si and PS materials, research is currently underway exploring 
the use of Si and PS for enhancing current medical device coatings by 
producing composite materials and also exploring the use of Si and PS as a 
standalone coating material, as well as drug delivery devices.  
E. G. Chadwick, O. M. Clarkin and D. A. Tanner 14
A novel approach to creating potential bioactive mesoporous silica 
coatings for implants was outlined by Gomez-Vega et al. in 2001. Here, Si 
substrates were etched in HF (5 vol. %) for 30 seconds to remove a silica 
layer. A substrate of Ti6Al4V was then coated with the mesoporous silica film 
(0.1 to 1µm) through a spin casting method using sol-gels as described [48]. 
After immersion for 7 days in SBF, hemispherical formations of apatite 
crystals with a leaf-like texture were observed on the surface of the coating 
material [48]. This outcome in-vitro, is indicative of the potential bone 
bonding ability of this bioactive coating material in-vivo [49].  
Since HA is already known to be bioactive and osteoconductive, it is 
therefore the current bioactive coating of choice for metallic implants. 
Investigations into combining this already osteoconductive material with Si 
and PS are underway due to the potential to enhance the bioactive properties, 
bonding ability and life-span of the coating at the implant-bone interface [50-
52]. Si itself is thought to positively affect the cellular response at the implant-
bone interface since Si is present in high concentration in metabolically active 
osteoblasts and considered critical in extracellular matrix formation in bone 
and cartilage [50]. Thian et al. investigated the in-vitro bioactivity of Si-doped 
HA coatings applied to a titanium substrate through magnetron co-sputtering 
in SBF. When comparing the as-sputtered HA (control sample) and Si-doped 
HA coatings it was revealed that a denser precipitated layer formed on Si-
doped HA showing improved bioactivity compared to the as-sputtered HA 
material[50]. The increased bioactivity of the Si-doped HA can be attributed to 
the chemical reactions between the SBF and the coating material. During the 
initial dissolution phase Ca (Ca2+) and P (P5+) ions are released into the SBF 
which increases the degree of super-saturation of SBF with respect to apatite. 
This facilitates the initial formation of CaP nuclei on the coating surface by 
consuming the Ca2+ and P5+ in the SBF [50]. CaP crystallite growth results in 
combination with the formation of additional nuclei creating a surface apatite 
layer.  
It is suggested that the incorporation of Si into the HA coatings results in 
Si4+ ions also attaching to the surface of the coating as SiO44+ ions thus 
inducing further sites for nucleation and crystallization of the apatite layer 
[50]. Annealing the sample has also been shown to increase the rate at which 
the apatite layer forms in-vitro. Gibson et al. has also reported that the 
incorporation of Si into HA enhances osteoblast cell activity and increases 
apatite formation in SBF when compared to phase-pure HA [53]. Sanchez et 
al. explored the modification of a PS substrate by coating with HA through 
cathodic bias in an electrochemical process in a cell culture study [54]. The 
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resultant material proved to have positive results showing proliferation of 
macrophages on the surface of the modified PS-HA material [54].  
An improvement in the mechanical properties of Si-incorporated coralline 
HA to Porous HA was achieved by Kim et al. showing an increase in 
compressive strength of up to 5.5 Mpa [55]. Niu et al. explored vacuum 
plasma spraying of Si coatings onto Ti6Al4V and showed improved in-vitro 
bioactivity when the samples were cleaned prior to SBF treatment at high 
temperature using de-ionized water [56]. It is proposed that the Si-OH groups 
which exist on the surface of the Si coating react with the hydroxyl ions in the 
SBF creating a negative charged surface with a Si-O- functional group [56]. 
This negative surface then attracts positive Ca2+ ions which are the first crucial 
ions needed to form an apatite layer. Adsorbtion of the Ca ions onto the 
surface coating results in hydrated precursor clusters containing Ca Hydrogen 
P. These clusters then grow by consuming the CaP ions in the SBF forming an 
amorphous CaP phase which later crystallizes into carbonate containing HA 
[56].  
The structure of the bond between bone and PS substituted HA was 
explored by Porter et al. in 2005 [57]. This in-vivo study explored the PS-HA 
bioceramic after it was placed into the distal femur of a rabbit and examined 
after a 6 week period. Results showed the growth of organized collagen fibers 
into the strut porosity at the bone PS-HA implant interface which then formed 
into mineralized fibrils within the implant [57]. It was observed that the apatite 
crystallites directly abutted and overlayed the Si-HA grains. Hence bone 
simply weaves over Si-HA forming a mechanical interlock and biological 
bond to the underlying ceramic [57].  
The majority of Si-HA coatings can be applied using plasma spraying, 
magnetron co-sputtering, sol-gel and pulse laser deposition [58]. Li et al. 
reported on the formation of uniform Si-HA phase coatings up to 1.4µm thick 
on commercially pure Ti substrates using an electrochemical deposition 
technique in electrolytes containing Ca2+, PO43- SiO33- ions with various molar 
ratios (nsi) [58]. This particular technique had a negative drawback which 
showed that the presence of Si in the electrolyte acts as an inhibitor to the 
growth of Si-Ha crystals leading to a decrease in potential coating thickness 
and results in overall changes to the HA crystal structure due to the loss of 
some OH- ions [58]. Zhang et al. studied the effects of HA and Si-HA coatings 
applied to porous Ti [59]. The porous Ti which had a pore size of up to 150-
600µm and a porosity of 67%, was prepared using a fiber sintering process.  
The HA and Si-HA coatings were applied to the porous Ti through a 
biomimetic coating process. In-vivo studies showed that the Bone In-Growth 
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rate (BIR) of the HA and Si-HA coatings were significantly higher than the 
uncoated porous Ti and that overall the Si-HA coated porous Ti displayed 
significantly higher BIR and highly improved surface bioactivity than the HA 
coated porous Ti [59]. Another study was conducted by Zhang et al. exploring 
the bioactivity of Si incorporated TiO2 (Si-TiO2) coatings compared to TiO2 
coatings and Ti plates [60]. The Si-TiO2 coating was prepared by Micro-Arc 
Oxidation (MAO) in a Ca, P, Si containing electrolyte. MAO is a plasma 
assisted electrochemical method that produces thick, rough and nano-
structured oxide films on Ti. Here MC3T3-C1 osteoblastic cells were seeded 
onto the three substrates with the Si-TiO2 showing the greatest cell attachment 
and proliferation. This was attributed to the Si releasing from the TiO2 
contributing to extracellular pH changes causing the structural alteration of the 
cell transmembrane proteins [60]. These altered proteins interact and bond 
with proteins adsorbed on the Si-TiO2 coatings from the culture medium 
promoting the attachment of the cells onto the surface. The porous surface 
structure is also thought to play a key role in attachment and proliferation [60]. 
 
 
POROUS SILICON IN DRUG DELIVERY  
AND THERAPEUTICS 
 
PS is increasingly being investigated for use as a potential material for 
drug delivery and therapeutics given its unique properties including high drug 
loading capacity, tunable surface porosity, heat and radiation stability, in-vivo 
biocompatibility and controlled release properties [61]. Prestidge et al. studied 
the loading of a model hydrophilic protein - papain into stain etched and 
anodized PS powders. Analysis concluded that the papain burst and sustained 
release is dependent on the PS type and loading level and that the loading of 
the protein was more efficient for the anodized PS than the stain etched PS 
[61]. Mesoporous Si microparticles were produced using thermal 
carbonisation (TCPSi) and thermal oxidation (TOPSi) to create particle 
surfaces which were suitable for drug administration applications [62]. The 
loading of five drugs (antipyrine, ibuprofen, griseofulvin, ranitidine and 
furosemide) into the microparticles and their subsequent release behavior was 
examined [62]. The loading efficiencies varied between 9%-45% while the 
release rate was dependant on the characteristic dissolution behavior of the 
drug substance. When the dissolution rate was high the microparticles caused a 
delayed release [62]. Providing controlled and localised release of therapeutics 
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within the body are essential objectives for improving efficiency and reducing 
the risks of potential side effects [1].  
The low toxicity of PS, its high porosity and tunable surface chemistry has 
created a surge of interest in developing PS as a potential mothership for 
therapeutics, diagnostics and other types of payloads [1]. PS was previously 
explored as a potential therapeutic agent for cancer treatment [63]. 
Photodynamic therapy (PDT) has some short and long-term side effects arising 
from reactive oxygen species (ROS). Single-walled carbon nano tubes (CNT) 
combined with near-infrared (NIR) light irradiation developed significant 
interest due to their heat generation capability and potential to develop them as 
therapeutic nano-bomb agents [63]. This particular PS study showed that the 
surface temperature of PS increased as quickly and as high as CNT and this 
generated heat is sufficient to kill off cancer cells. The PS was also found to 
produce smaller amounts of ROS than CNT during NIR light irradiation [63].  
Mesoporous Si was developed as a multistage delivery system for imaging 
and therapeutic applications [64]. The mesoporous Si particles were 
biodegradable and biocompatible with well controlled shapes, sizes and 
porosity and able to carry, release over time and deliver nanoparticles to 
primary endothelial cells [64]. Another study investigated the interaction of 
B50 rat hippocampal cells with stain-etched PS [65]. These cells showed a 
clear preference for the PS material surface compared to an untreated surface 
and it was observed that the network pattern is influenced by a single neuron 
response to the material surface nature and topology [65]. Mesoporous silica 
nanoparticles (MSN’s) showed the ability to carry basic fibroblast growth 
factors (bFGF), proteins which play a key role in wound healing and blood 
vessel regeneration [66]. PS is similar to MSN’s in that they have well 
documented surface properties, tunable pore sizes and very large surface areas 
making them ideal candidates for drug delivery devices, therapeutics and cell 




ANALYSIS OF A BIOACTIVE METALLURGICAL GRADE 
NANO-POROUS SILICON PTFE COMPOSITE 
 
A polytetrafluoroethylene (PTFE) MGPS composite sheath structure was 
purchased from Vesta Sciences (Hisings Backa, Sweden). This composite 
consisted of fused PTFE beads (Dupont No.60 Teflon™) with embedded 
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MGSi microparticles which had been chemically etched to produce a 
nanoporous structure.  
The MGSi microparticles were chemically etched in a similar fashion to 
sample 2E-100 (2E-100 – MGPS powder manufactured from the 2E-Bulk 
powder after chemically etching for 100% of the required etching time (100% 
etching time is defined as the point when the sample exhibits 
photoluminescence with an ultraviolet light [30]). Particle size was around 
4µm with the surface area at 157m2g, pore volume at 0.3cc/g and pore size is 
an average of 5.9nm. SBF was produced in accordance with published 
methods [36, 67].  
Reagents were dissolved in sequential order (as per Table 2) into 500 mL 
of purified water (Reagecon, Shannon, Ireland) using a magnetic stirrer. The 
solution was maintained at 36.5 ±1.5 ˚C using a water bath. One mole HCl 
was titrated to adjust the pH of the SBF to 7.40. Purified water was then added 
to adjust the total volume of liquid to one litre. Once prepared, the SBF was 
stored for 24 h (5 ˚C) to ensure that no precipitation occurred.  
Composite structures were cut into appropriately sized samples and 
immersed in a calculated quantity of simulated body fluid (SBF), such that 
equation 3 was satisfied: 
 
Vs = Sa/10       (Equation 3) 
 
where Vs is the volume of SBF (ml) and Sa is the surface area of the specimen 
(mm2). Specimens in SBF were stored in plastic containers and maintained at 
37±1˚C for 1, 7 and 14 days. After removal from SBF, each sample was gently 
rinsed with purified water, placed on individually labelled sheets of filter paper 
and left in desiccators at room temperature to dry. After removal from SBF 
solutions, a JEOL JSM-840 scanning electron microscope (JEOL Ltd., Tokyo, 
Japan) equipped with a Princeton Gamma Tech (PGT) Energy Dispersive X-
ray (EDX) system (Princeton Gamma Tech UK Ltd., Peterborough, UK) was 
used to obtain secondary electron images and carry out chemical analysis of 
the surface of the composites. All EDX spectra were collected at 20 kV, using 
a beam current of 0.26 nA. Quantitative EDX converted the collected spectra 
into concentration data by using standard reference spectra obtained from pure 
elements under similar operating parameters. A Phillips Xpert MPD Pro 
3040/60 X-ray Diffraction (XRD) Unit (Phillips, Amsterdam, Netherlands) 
was used to perform thin film XRD (TF-XRD) on the surface of the 
composites after immersion in SBF to analyze the crystallinity of the CaP 
layer formed. 
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Table 2. Order and amounts of reagents used to prepare 1,000 mL of SBF 
 
Order Reagent Quantity 
1  NaCl 8.035 g 
2  NaHCO3 0.355 g 
3  KCl 0.225 g 
4  K2HPO4.3H2O 0.231 g 
5  MgCl2.6H2O 0.311 g 
6  1.0 M-HCl 39 mL 
7  CaCl2 0.292 g 
8  Na2SO4 0.072 g 
9  Tris 6.118 g 
10  1.0 M-HCl 0–5 mL 
 
TF-XRD was run between 25 and 45 degrees 2-theta, using a generator 
voltage of 40 Volts and a tube current of 40 Amps, a step size of 0.017 degrees 
2-theta and a step time of 40.72 s. A Varian 610-IR Attenuated Total 
Reflection Fourier Transform Infrared (ATR-FTIR) spectrometer was used to 
examine changes to the functional groups of the samples after each time period 
of immersion in SBF. 32 ATR-FTIR scans were averaged between 4000 and 
500 cm-1, with a resolution of 4 cm-1. The SBF solutions, after removal of the 
composite material, were filtered using Watman filter paper (1µm nominal 
pore size) and acidified (to maintain dissolution and prevent any re-
precipitation during analysis) by making up 5 ml of SBF to 25 ml using 2 
vol.% nitric acid. Standards were purchased (Reagecon, Shannon, Ireland) and 
suitably diluted, such that a linear correlation could be made within the range 
of the SBF samples. Inductively Coupled Plasma-Optical Emission 
Spectroscopy (ICP-OES) was run on standards and samples and 2 vol. % nitric 
acid was used to clean out lines between runs.  
As indicated in Figure 4, the MGPS particles are clearly visible above the 
teflon tape. As might be expected, SEM-EDS analysis reveals only the 
presence of Si, O and fluorine (F), (Figure 5a) which are due to Si from the 
particles, F from the etching process and O from the surface oxide on the 
teflon tape [32]. However, post-immersion in SBF, the MGPS-PTFE 
composite exhibits precipitation of a needle-like morphology on its surface. 
EDX analysis reveals that this precipitate consists of Ca, P and Si, with small 
amounts of sodium (Na) and magnesium (Mg) incorporation (Figure 5b). 
From the SEM analysis it was evident that the MGPS-PTFE composite could 
induce the rapid formation of bone-like apatite on its surface in SBF.  






Figure 4. SEM of the MGPS-PTFE composite before (a) and after (b) immersion in 
SBF for 14 days. 
Apatite spherulites formed on the MGPS-PTFE of > 1µm in size were 
observed after 14 days in SBF and the Ca/P ratios observed were consistent 
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b) 
 
Figure 5. EDX analysis of MGPS-PTFE composite before (a) and after (b) immersion 
in SBF. 
Thin film X-ray diffraction (TF-XRD) of the fully etched sample (Figure 
6) reveals that the precipitate is crystalline in nature and is indeed crystalline 
HA.  
It can be observed from Figure 6 that after only 1 day of immersion in 
SBF there is evidence of a small HA peak at approximately 26 degrees 2-theta. 
This 100% HA peak continues to grow between 1 and 14 days of immersion in 




Figure 6. TF-XRD of the MGPS-PTFE composite at different immersion times in SBF. 
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Figure 7. ICP-OES of SBF after different periods of MGPS-PTFE composite 
immersion. 
Inductively coupled plasma-optical emission spectroscopy (ICP-OES) 
analysis of the remaining SBF solutions after immersion studies indicated a 
linear reduction in Ca and P content with immersion time (Figure 7), as might 
be expected with the surface precipitation of HA on the composite. However, 
Si content in the solution was observed to increase after 1 day of immersion 
and linearly decrease thereafter. This would indicate that initial degradation of 
the Si particles occurs, followed by uptake by the precipitating HA. This 
indicates that the initial HA precipitation observed (after 1 day) may be either 
Si free or have a low Si content, followed thereafter (7 and 14 days) by 
precipitation of a Si-rich HA phase. This initial Si release into solution, as well 
as the subsequent uptake in the HA structure will likely be beneficial from a 
therapeutic prospective. 
The microparticles used in this MGPS-PTFE composite material are 
similar to the ones used in a previous study by Chadwick, Clarkin and Tanner 
which showed that the powder induced bone-like apatite formation on its 
surface in SBF [67]. Previous TEM analysis of the surface of the MGPS 
particles indicated the presence of a dense surface layer of large particle-like 
aggregates of needle shaped crystals, typified by the image in Figure 8a. Nano-
beam diffraction analysis indicated a crystalline structure as shown by Figure 
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8b. The crystal structure was matched to HA in the JPDS database (reference 
number 01-1008) [67].  
The simulated diffraction pattern is indicated in Figure 8b. The results 
shown were found to be representative of the sample as a whole, after a 
number of different areas were studied. The compositional elements of the 
surface layer, as identified by EDX indicate the presence of Ca, P and Si 
within the crystalline structure (see Figure 8c). The lower region on the left of 
the image in Figure 8a shows the MGPS area covered by the dense crystalline 
apatite layer.  
 
 
Figure 8. (a) Bright Field TEM micrograph of surface apatite layer of sample (a) after 
30 day immersion in SBF (b) Nano-Beam diffraction pattern from (a) showing 
crystalline structure (c) Inset on the top left shows the Line-EDX analysis starting from 
left to right as indicated by the line at the bottom of the image (The MGPS region is on 
the left of the line while the needle-like apatite structure is on right) [67]. 
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The line across this selected area represents the TEM Line EDX spectra in 
Figure 8c. The high Si peak shows the initial MGPS region which is then 





PS has the potential to serve as a biomaterial with a wide range of 
applications. It has both tunable and controllable surface properties and 
characteristics favouring the material ahead of most other potential 
applications. It has already been proven as biocompatible, biodegradable and 
can also assist in tailoring current market biomaterials and surface coatings to 
have improved bioactivity both in-vitro and in-vivo. PS is increasingly being 
investigated for drug delivery and therapeutic applications given its unique 
properties including high drug loading capacity, surface porosity, heat and 
radiation stability, and controlled release properties. Current orthopedic 
devices consist mainly of CoCr or Ti which are then surface coated with HA to 
induce osteointegration and bone bonding in-vivo. PS and Si has been shown 
to enhance this bone bonding ability and improve the bioactivity of such 
devices by incorporation of Si into HA. Given the drug loading capabilities of 
PS one could develop a suitable device which not only improves the 
bioactivity of current market HA coatings but which could be fully loaded 
with growth factors to further stimulate bone healing at the implant site. This 
would result in a longer lasting and a more permanent solution to current 
orthopaedic implants and would also allow greater health benefits for the 
patient. The potential to expand and combine this research and further 
integrate it into the therapeutics fields seems limitless. The authors also 
present current work on characterising bioactive MGPS particles and a 
bioactive MGPS-PTFE composite material which have the potential to be 
further developed for suitable bone bonding applications or a guided bone 
regeneration device. The composite material was examined after SBF trials 
and initiated deposition of a ‘bone-like apatite’ on its surface after only 1 day 
of immersion. This ‘bone-like apatite’ contains Si incorporated into its 
structure, which is known to improve apatite’s biocompatibility and results in 
increased cellular differentiation and bone growth. Due to its reactivity in-vitro 
and its nanoporous sponge structure, this material exhibits potential for use in 
bony applications, as well as in drug delivery device applications. This device 
may be used as an enhanced bioactive platform for the incorporation and 
delivery of various pharmacological and biological agents in-vivo. 
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